A NEW HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND TABLET DOSAGE FORM

Authors

  • B. V. SUMA Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bangalore, India
  • DEVESWARAN R. Department of Pharmaceutics, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bangalore, India, Drug Design and Development Centre, M. S. Ramaiah University of Applied Sciences, Bangalore, India
  • PREMNATH SHENOY Drug Design and Development Centre, M. S. Ramaiah University of Applied Sciences, Bangalore, India

DOI:

https://doi.org/10.22159/ijpps.2019v11i8.34339

Keywords:

Dapagliflozin, HPTLC, Method development, Validation

Abstract

ABSTRACT

Objective: To develop a new simple, selective and precise high-performance thin layer chromatographic method for determination of Dapagliflozin (DAPA) in bulk and tablet dosage form

Methods: The present study describes development and validation of High performance thin layer chromatographic method for DAPA. The chromatographic separation was carried out on Merck precoated silica gel aluminium plate 60 F254 using Chloroform: Methanol (9:1v/v) as mobile phase. Quantitative determination of drug was carried out by densitometric scanning of plates at 223 nm using Camag TLC Scanner.

Results: The chromatographic condition shows compact band with the retention factor for dapaglifloxin as 0.21 ± 0.004. The method was validated as per ICH guidelines for linearity, accuracy, precision and robustness. Response was found to be linear in the concentration range of 400 ng/ band to 1200 ng/band with linear regression value of 0.9953 with respect to peak area and concentration value The LOD and LOQ was found to be 1.2083 ng/band and 3.6616ng/ band. The percentage assay was found to be 100±0.05.

Conclusion: This method under statistical analysis proved a selective, repeatable and accurate analysis of the drug. This method can be used for quantitative analysis of dapaglifloxin in the bulk drug and in tablet.

 

 

Downloads

Download data is not yet available.

References

https://www.drugbank.ca/drugs/DB06292. [Last accessed on 10 Jun 2018]

Gajanan VM, Krishna RG, Atul TH. Estimation of dapagliflozin from its tablet formulation by UV-spectrophotometry. Pharm Methods 2017;8:102-7.

Karuna PC, China E, Basaveswara Rao MV. Unique UV spectrophotometric method for reckoning of dapagliflozin in bulk and pharmaceutical dosage forms. J Chem Pharm Res 2015;7:45-9.

Yunoos M, Sankar DG. A validated stability-indicating high performance liquid chromatographic method for simultaneous determination of metformin HCl and dapagliflozin in bulk drug and tablet dosage form. Asian J Pharm Clin Res 2015;8:320-6.

Shakir Basha S, Sravanthi P. Development and validation of dapagliflozin by reverse-phase high-performance liquid chromatography method and its forced degradation studies. Asian J Pharm Clin Res 2017;10:101-5.

Asmita M, Chandanam SR, Akkamma HG, Arpitha S, Krishna PT. Analytical method development and statistical validation of dapagliflozin in tablet dosage form and bulk drug. Indian Res J Pharm Sci 2018;16:1344-56.

Gunasekar M, Ahmed MI, Zeyad MA. Stability indicating RP-HPLC method development for simultaneous determination and estimation of dapagliflozin in raw and tablet formulation. Chem Res J 2018;3:159-64.

Jitendra D, Sundeep K, Sajal KJ, Amjad K. A new RP-HPLC method development and validation of dapagliflozin in bulk and tablet dosage form. Int J Drug Delivery Res 2017;9:2-4.

Mante GV, Hemke AT, Umekar MJ. RP-HPLC method for estimation of dapagliflozin from its tablets. Int J Chem Tech Res 2018;11:242-8.

Mitali V, Chirag JP, Patel MM. Development and stability-indicating HPLC method for dapagliflozin in API and pharmaceutical dosage form. Int J Appl Pharm 2017;9:33-41.

Sanjeev KS, Bonagani N, Vadicherla S, Merugu M. Stability indicating RP-HPLC method development and validation of dapagliflozin in bulk and pharmaceutical dosage form. Indo Am J Pharm 2017;3:321-9.

Subrata S, Vipul PP. Method development and validation of dapagliflozin drug in bulk and tablet dosage form by RP-HPLC. Int J Pharma Res Health Sci 2017;5:1755-9.

Aubry AF, Gu H, Magnier R, Morgan L, Xu X, Tirmenstein M, et al. Validated LC-MS/MS methods for the determination of dapagliflozin, A sodium-glucose co-transporter 2 inhibitors in normal and ZDF rat plasma. Bioanalysis 2010;2:2001-9.

Sally Nasser, Ismail Salama, Samia M Mostafa, Mohamed Saleh Elgawish. Comparative high-performance liquid chromatographic and high-performance thin-layer chromatographic study for the simultaneous determination of dapagliflozin and metformin hydrochloride in bulk and pharmaceutical formulation. J Planar Chromatography-Modern TLC 2018;31:469-76.

Shveta H, Parmar, Shailesh VL, Sachin BN. Development and validation of UV-spectroscopic first derivative and high-performance thin-layer chromatography analytical methods for simultaneous estimation of dapagliflozin propanediol monohydrate and saxagliptin hydrochloride in synthetic mixture. Eur J Biomed Pharm Sci 2018;5:668-81.

ICH, Q2B Validation of Analytical Procedure: Methodology, in: Proceeding of the International Conference on Harmonization, Geneva; 1996. Available from: https://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guidelines. [Last accessed on 10 Apr 2019].

Published

01-08-2019

How to Cite

SUMA, B. V., D. R., and P. SHENOY. “A NEW HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND TABLET DOSAGE FORM”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 11, no. 8, Aug. 2019, pp. 58-63, doi:10.22159/ijpps.2019v11i8.34339.

Issue

Section

Original Article(s)